Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk

NCT03076034 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT03076034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03076034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 26, 2015
Completion date
November 30, 2028
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

distal radius fracture, hip fractures, osteoporosis